Catalyst Capital Advisors’s Genfit GNFT Stock Holding History

Catalyst Capital Advisors’s Portfolio GNFT Stock Details GNFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-272	Closed	-$7K	–	441
2019 Q1	$7K	Buy	+272	New	+$6.28K	﹤0.01%	326

Other funds holding GNFT

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Catalyst Capital Advisors's GNFT Position: Q2 2019 in Review

Catalyst Capital Advisors sold out of Genfit (GNFT) in Q2 2019, closing a stake of 272 shares — an estimated $7K sold.

Catalyst Capital Advisors first reported a position in GNFT in Q1 2019 and held it in 1 quarter. The position peaked at $7K in Q1 2019. 24 funds tracked by Wall St. Rank hold GNFT as of Q2 2019.

Catalyst Capital Advisors reported no remaining Genfit position as of Q2 2019 after selling out during the quarter.
Catalyst Capital Advisors sold 272 Genfit shares in Q2 2019, an estimated $7K.
Catalyst Capital Advisors first reported a position in Genfit in Q1 2019 and held it in 1 quarter.
Catalyst Capital Advisors's Genfit position peaked at $7K in Q1 2019.
24 funds tracked by Wall St. Rank held Genfit as of Q2 2019.

Based on Catalyst Capital Advisors's 13F filing for Q2 2019, filed 8 Aug 2019.